In the EGFR and ALK wild-type non-squamous subgroup, ICI increased the risk of CIP of all grades compared to chemotherapy (OR = 2.72, 95% CI 1.54–4.82, p = 0.0006). The gene discussed is ALK; the disease is hereditary sensory and autonomic neuropathy.